Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of A. Simon Pickard

A. Simon Pickard


Professor, College of Pharmacy - Pharmacy Systems Outcomes and Policy
Associate Head, PSOP
Assistant Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research

Overview:
A. Simon Pickard, PhD, is a Professor in the Department of Pharmacy Systems, Outcomes and Policy, and Assistant Director of the Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois – Chicago College of Pharmacy. He earned his B.Comm., B.Sc. in Pharmacy, and PhD in Pharmacy and Pharmaceutical Sciences from the University of Alberta in Edmonton, Alberta, Canada. Dr. Pickard has authored over 150 publications on evaluating the safety, effectiveness and value of health care interventions; improving drug-related outcomes through education (particularly opioids); and on the measurement and evaluation of quality of care and health outcomes. He has served on several editorial boards, including Medical Decision Making, Drugs in Context, and Quality of Life Research. He is co-developer of the LupusPRO, a lupus specific quality of life measure. He has extensively contributed to the EuroQol Group, developers of the EQ-5D, one of the most widely used measures of health in clinical trials throughout the world, and is part of the international consortia to develop a new measure of health and well-being (EQ-HWB). Dr. Pickard was named University Scholar in 2023, awarded to outstanding faculty by the President of the University of Illinois System.

Research Interests:
Dr. Pickard’s research interests involve evaluating the safety, effectiveness and value of health care interventions; improving drug-related outcomes through education (particularly opioids); and on the measurement and evaluation of quality of care and health outcomes. H

Teaching Statement:
Dr. Pickard is an educator in the UIC professional program (PharmD) and graduate program (PhD/MS). In the PharmD program, he initiated an elective course starting Fall 2022 that provides an overview of health economic and outcomes research (HEOR). He serves as preceptor for P4 PharmD students in advanced clerkships rotations offered each year focusing on research activities related to pharmacy systems, outcomes and policy. In the PhD program for PSOP, he teaches a course on measurement and evaluation of patient-reported outcomes (PSOP 555) and an introduction to comparative effectiveness research (PSOP 516). He serves as main advisor for PhD/MS students, and as a committee member on department qualifiers, preliminary exams and dissertation defenses. He has served as a director for numerous (post-doc) fellowships in partnership with industry since 2007, including TAP, Takeda, NovoNordisk, and Pfizer.

Ph.D. Thesis Research (PSOP 599), 8/25/2025 – 12/5/2025
Independent Study (PSOP 596), 8/25/2025 – 12/5/2025
Hlth Econ & Outcomes Research (PSOP 489), 8/25/2025 – 12/5/2025
Concentration Research (PSOP 485), 8/25/2025 – 12/5/2025
PSOP Project (PSOP 597), 1/13/2025 – 5/2/2025
Patient Reported Outcomes (PSOP 555), 1/13/2025 – 5/2/2025
Independent Study (PSOP 596), 1/13/2025 – 5/2/2025
Ph.D. Thesis Research (PSOP 599), 1/13/2025 – 5/2/2025
Ph.D. Thesis Research (PSOP 599), 8/26/2024 – 12/6/2024

Selected Grants

Testing the EQ-HWB modifications in a multi-country mixed patient population � US arm, Euroqol Group Business Mgmt., 1/6/2025 - 7/5/2026, Obligated Amount: $66793.13; Anticipated Amount: $66793.13

ILPMP - UIC Prescription Monitoring Academic Detailing FY24-FY26, Illinois Department of Human Services., 4/3/2024 - 9/30/2025, Obligated Amount: $400000; Anticipated Amount: $400000

FY24 and FY25 Overdose Data to Action-States (OD2A-S) Program Evaluation, Illinois Department of Public Health., 9/1/2023 - 6/30/2025, Obligated Amount: $320834; Anticipated Amount: $320834

UIC-DPH OD2A Eval Work Order Number: 32600027K, Illinois Department of Public Health., 9/1/2022 - 8/31/2023, Obligated Amount: $300000; Anticipated Amount: $300000

Pfizer 2022 to 2025 Fellowship - Pickard, Pfizer Inc., 7/1/2022 - 6/30/2025, Obligated Amount: $482934; Anticipated Amount: $482934

Self-perceived burden, caregiver burden and EQ measures �assessing measurement overlap, EuroQol Group., 5/1/2022 - 5/1/2025, Obligated Amount: $137909; Anticipated Amount: $137909

UIC Prescription Monitoring Academic Detailing - contract 49I1127M40, Illinois Department of Human Services., 12/30/2020 - 8/31/2023, Obligated Amount: $510000; Anticipated Amount: $510000

OD2A Year 2 and 3 Evaluation IGA, Illinois Department of Public Health., 9/1/2020 - 8/31/2022, Obligated Amount: $600000; Anticipated Amount: $600000

PhD dissertation funding request for a novel valuation method, Euroqol Group Business Mgmt., 8/16/2020 - 8/15/2022, Obligated Amount: $50163; Anticipated Amount: $50163

Selected Publications

Joshi, Mrinmayee, Kim, Kibum, Pickard, A Simon, Sharp, Lisa K, Gerber, Ben S, Touchette, Daniel R. (2025). Long-term cost-effectiveness of a mobile health intervention delivered by clinical pharmacists and community health workers for type 2 diabetes management in urban African American and Latinx populations. American Journal of Health-System Pharmacy, zxaf318. doi:10.1093/ajhp/zxaf318.

Kuharic, Maja, Su, Neo Hsuanyun, Pickard, A Simon. (2025). Reversing Proxy Roles: Care Recipients as Proxies for Caregiver Health-Related Quality of Life. Value in Health. doi:10.1016/j.jval.2025.10.012.

Joshi, Mrinmayee, Pickard, A Simon, Kim, Kibum, Sharp, Lisa K, Gerber, Ben S, Touchette, Daniel R. (2025). Health-related quality of life in racial and ethnic minority adults with type 2 diabetes: validity and responsiveness of the EQ-5D-3L. Quality of Life Research, 34, (11), 3147-3158. doi:10.1007/s11136-025-04070-2.

Pickard, A Simon, Nazari, Jonathan L, Ramos-Goñi, Juan M, Gu, Ning Yan. (2025). Valuing child health: an EQ-5D-Y-3L value set for the United States. Value in Health. doi:10.1016/j.jval.2025.11.003.

Kuharic, Maja, Yu, Justin, Joshi, Mrinmayee, Nazari, Jonathan, Zecic, Fatih, Cella, David, Pickard, A Simon. (2025). Patient-Reported Outcome Measures in Clinical Trials: An Analysis of Trends from 2008-2023. Value in Health. doi:10.1016/j.jval.2025.10.017.

Norman, R, Campbell, R, Rowen, D, Viney, R, Street, DJ, Müller, F, Mercieca-Bebber, R, Pickard, AS, Cella, D, Shaw, JW, King, MT. (2025). United Kingdom value set for the functional assessment of cancer therapy eight dimension (FACT-8D) preference-based quality of life instrument. The European Journal of Health Economics, 1-14. doi:10.1007/s10198-025-01844-w.

Nasser, Soumana C, Pickard, A Simon, Nazari, Jonathan L, Kuharic, Maja. (2025). Frequency and severity response scales for pain and discomfort: psychometric insights from EQ-HWB. Quality of Life Research, 34, (8), 2259-2268. doi:10.1007/s11136-025-04003-z.

Joshi, Mrinmayee, Kim, Kibum, Pickard, A Simon, Sharp, Lisa, Gerber, Ben S, Touchette, Daniel. (2025). EE496 Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management. Value in Health, 28, (6), s153. doi:10.1016/j.jval.2025.04.2092.

Kuharic, Maja, Pickard, A Simon. (2025). PCR30 Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences. Value in Health, 28, (6), s315. doi:10.1016/j.jval.2025.04.1353.

Notable Honors

2023, University Scholar, University Scholar Program

Education

Degrees:
Ph.D., University of Alberta, Canada, 2002
B.Sc, University of Alberta, Canada, 1996
B. Comm, University of Alberta, Canada, 1991